New techniques tackle legacy CT dose monitoring

Jul 4, 2011
2011 06 29 12 24 15 972 Clunie 960
2011 06 29 12 24 15 972 Clunie 960
DoseUtility user interface. Image courtesy of David Clunie.

close

Latest in Clinical News
Cash Bills
Leo Cancer Care nets $65M to deploy proton therapy system
July 8, 2026
Atom Nuclear Lab Thumb
GE HealthCare, Mayo Clinic begin new theranostics trial in Minnesota
July 8, 2026
Alturion
Philips launches new ultrasound system
July 8, 2026
Lungs 3 D Research 400
AR-guided localization may sub for CT for early-stage lung cancer
July 8, 2026
Related Stories
2011 07 01 14 43 34 514 Fdg Pet Fetus Thumb
Nuclear Medicine
FDG-PET has low radiation risk to fetus in pregnant patients
2011 06 29 12 11 00 224 Kennedy 577
Clinical News
New techniques tackle legacy CT dose monitoring
2011 06 29 12 24 15 401 Clunie 200
PACS/VNA
New techniques tackle legacy CT dose monitoring
2011 06 30 15 41 01 607 18 Phantoms Thumb
CT
New phantoms ramp dose estimate accuracy for imaging exams
More in Clinical News
Leo Cancer Care nets $65M to deploy proton therapy system
By AuntMinnie.com staff writers
Stanford Medicine used the system to treat a pediatric brain tumor patient on June 4.
July 8, 2026
Cash Bills
GE HealthCare, Mayo Clinic begin new theranostics trial in Minnesota
By AuntMinnie.com staff writers
First U.S. site to investigate the StarGuide GX SPECT/CT technology.
July 8, 2026
Atom Nuclear Lab Thumb
Philips launches new ultrasound system
By AuntMinnie.com staff writers
The system features AI-powered workflows and is designed for high-volume clinical environments.
July 8, 2026
Alturion
AR-guided localization may sub for CT for early-stage lung cancer
By Amerigo Allegretto
AR-guided localization was noninferior to conventional CT guidance and led to better patient experiences.
July 8, 2026
Lungs 3 D Research 400
Imagion extends collaboration with Siemens on MRI contrast agent
By AuntMinnie.com staff writers
Siemens will provide in-kind expertise and technical support to clinical sites.
July 8, 2026
Ai Handshake
Study backs LDCT lung cancer screening in Singapore
By Will Morton
Lung cancer is the leading cause of cancer death in Singapore, with approximately 48% of cases occurring in individuals who have never smoked.
July 8, 2026
Lungs
New criteria evaluates treatment response in bone metastases
By Will Morton
RECIBM-defined response classifications showed high agreement with established criteria and reclassified 19% of patients.
July 7, 2026
Response Evaluation Criteria in Bone Metastases (RECIBM) and metabolic criteria were used to detect a complete response missed at anatomic assessment. A 76-year-old male patient presented with 1 month of hemoptysis and was diagnosed with small cell lung cancer and bone metastases. Baseline (July 2022) F-18 FDG-PET/CT images (A, maximum intensity projection image; B–E, axial images) demonstrate FDG-avid lesions in the left lamina of the first lumbar vertebra (L1) (straight yellow arrows; maximum standardized uptake value, 2.74; peak standardized uptake value normalized to lean body mass, 1.59) and left ilium (curved yellow arrows; maximum standardized uptake value, 3.68; peak standardized uptake value normalized to lean body mass, 2.28). After seven chemotherapy cycles (December 2022), follow-up PET/CT images (F, maximum intensity projection image; G–J, axial images) show complete metabolic resolution of bony lesions (L1: maximum standardized uptake value, 1.32, and peak standardized uptake value normalized to lean body mass, 0.85; left ilium: maximum standardized uptake value, 1.48, and peak standardized uptake value normalized to lean body mass, 0.82), without apparent osteolytic or osteoblastic changes at CT. Assessment was stable disease (SD) according to the University of Texas MD Anderson Cancer Center (MDA) criteria but complete response (CR) or complete metabolic response (CMR) according to RECIBM, PET Response Criteria in Solid Tumors (PERCIST), and European Organization for Research and Treatment of Cancer (EORTC) criteria. The patient was alive as of September 30, 2025.
CT sign may flag who benefits from subdural hematoma procedure
By Will Morton
Among participants with the “the hyperdense capsule sign,” middle meningeal artery embolization resulted in significant benefits over usual care.
July 7, 2026
Representative axial noncontrast CT images with and without the hyperdense capsule sign (HDCS). The HDCS is defined as a hyperdense capsule layer of linear shape surrounding a subdural hematoma (SDH). (A–D) Images of SDH with the HDCS (arrowheads). (E–H) Images of SDH without the HDCS.
Microbot Medical reports over 100% revenue growth in Q2
By AuntMinnie.com staff writers
The revenue gains follow the full market release of the company's Liberty Endovascular Robotic System.
July 7, 2026
Research Money 400
Cleerly to debut customizable full text reports at SCCT 2026
By AuntMinnie.com staff writers
The new capabilities allow provider teams to configure sections, field order, and headings to match individual clinical workflows.
July 7, 2026
Heart Artificial Intelligence Ai 400
Trice Imaging launches obstetrics reporting tool for fetal medicine
By AuntMinnie.com staff writers
The tool aims to support standardized report turnaround, clinical decisions, and operational efficiency for fetal medicine.
July 7, 2026
Ultrasound Gynecologist 400
VB Spine acquires CT-to-fluoroscopy technology for spine navigation
By AuntMinnie.com staff writers
The CT-Fluoro tech allows surgeons to register a patient's preoperative CT scan using standard fluoroscopic imaging.
July 7, 2026
Vb Spine Logo Purple
Page 1 of 3777
Next Page